Anbio Biotechnology Class A Ordinary Shares (NNNN)
Stock · NASDAQ · Health Care
$3.33as of 10/16/2026
Price chart
Active signals
NNNN Signal Track Record
How signals performed across all stocks →What NNNN's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.
| Signal | Times | Median 20-session return | Higher after 20 sessions | Last signal |
|---|---|---|---|---|
| Volume Spike | 9 | -27.6% | 22% | September 23, 2026 |
| Bollinger Band Breakdown | 5 | +7.9% | 60% | October 5, 2026 |
| Bollinger Band Breakout | 5 | -14.6% | 40% | May 19, 2026 |
| Any 20-session window (baseline) | -14.6% | 29% |
Computed by MarketWall from daily closing prices since December 3, 2025. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.
About NNNN
Anbio Biotechnology provides in vitro diagnostics (IVD) products in the European Union, the Asia Pacific, North America, South America, and internationally. The company offers lateral flow immunoassay, fluorescence immunoassay, loop-mediated isothermal amplification, SHA dry chemistry, chemiluminescence immunoassay, and real-time polymerase chain reaction solutions; and SARS-CoV-2 and SARS-CoV-2/Flu A/Flu B antigen r…
- Sector
- Health Care
- Industry
- Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Employees
- 27
- Website
- anbiobiotechnology.com/
Fundamentals
- 1-day range
- $3.09$3.7
- Market cap
- $1.40B
- P/E (trailing)
- 46.55
- P/E (forward)
- —
- EPS (trailing)
- $0.23
- Dividend yield
- —
- Beta
- 1.71
- Avg. volume
- 148.0K
Anbio Biotechnology Class A Ordinary Shares Competitors
Chosen by industry and closest market cap.
- NNNNAnbio Biotechnology Class A Ordinary Shares$3.13▼ 5.15%Market cap $1.40BP/E 46.55$3.52$44.73
- NTLAIntellia Therapeutics Inc. Common Stock$11.42▲ 0.71%Market cap $1.57BP/E —$7.95$28.25
- QDELQuidelOrtho Corporation Common Stock$12.91▼ 7.19%Market cap $1.11BP/E —$9.92$35.58
- ACHVAchieve Life Sciences Inc. Common Shares$6.38▼ 8.46%Market cap $672.42MP/E —$2.62$8.64
- TKNOAlpha Teknova Inc. Common Stock$7.08▼ 6.84%Market cap $350.10MP/E —$1.91$9.48
- NEOGNeogen Corporation Common Stock$11.81▼ 3.75%Market cap $2.46BP/E —$5.37$14.26
- MYGNMyriad Genetics Inc. Common Stock$3.98▼ 8.51%Market cap $304.17MP/E —$2.74$8.59
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| NNNN Anbio Biotechnology Class A Ordinary Shares | $1.40B | 46.55 | $3.13 | ▼ 5.15% | $3.52$44.73 |
| NTLA Intellia Therapeutics Inc. Common Stock | $1.57B | — | $11.42 | ▲ 0.71% | $7.95$28.25 |
| QDEL QuidelOrtho Corporation Common Stock | $1.11B | — | $12.91 | ▼ 7.19% | $9.92$35.58 |
| ACHV Achieve Life Sciences Inc. Common Shares | $672.42M | — | $6.38 | ▼ 8.46% | $2.62$8.64 |
| TKNO Alpha Teknova Inc. Common Stock | $350.10M | — | $7.08 | ▼ 6.84% | $1.91$9.48 |
| NEOG Neogen Corporation Common Stock | $2.46B | — | $11.81 | ▼ 3.75% | $5.37$14.26 |
| MYGN Myriad Genetics Inc. Common Stock | $304.17M | — | $3.98 | ▼ 8.51% | $2.74$8.59 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
- 12 Health Care Stocks Moving In Friday's After-Market SessionBenzinga · 10/2/2026
See the full, filterable feed with live charts on the MarketWall dashboard.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 3, 2026
Anbio (NNNN) Featured in After-Market Movers List
Anbio Biotechnology was included in a list of health care stocks moving in Friday's after-market session. This indicates the stock experienced notable price action outside regular trading hours. The company remains a high-beta name with a wide 52-week range, reflecting its volatile trading history.
Anbio (NNNN) Featured in After-Market Movers List. Anbio Biotechnology was included in a list of health care stocks moving in Friday's after-market session. This indicates the stock experienced notable price action outside regular trading hours. The company remains a high-beta name with a wide 52-week range, reflecting its volatile trading history.